Inventor · Dormagen, DE

Simone Greven

20Patents
5h-index
59Co-inventors
68Inventor score

Filing activity: Nov 18, 2010 → Apr 29, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US8992932B2 Binder-drug conjugates (ADCs) and use thereof Chemistry; Metallurgy 21 Active
US10022453B2 Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP) Chemistry; Metallurgy 14 Active
US10485880B2 Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylated anti-TWEAKR antibodies Human Necessities 11 Active
US10744205B2 Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with anti-CD123-antibodies Chemistry; Metallurgy 9 Active
US10973923B2 Site specific homogeneous with KSP inhibitors Chemistry; Metallurgy 8 Active
US11123439B2 Antibody drug conjugates (ADCS) and antibody prodrug conjugates (APDCS) with enzymatically cleavable groups Human Necessities 5 Active
US11478554B2 Antibody drug conjugates (ADCS) having enzymatically cleavable groups Human Necessities 4 Active
US9649374B2 Neutralizing prolactin receptor antibodies and their therapeutic use Chemistry; Metallurgy 4 Active
US11071788B2 Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodies Human Necessities 4 Active
US11001636B2 Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodies Chemistry; Metallurgy 4 Active
US11685714B2 Prodrugs of cytotoxic active agents having enzymatically cleavable groups Chemistry; Metallurgy 2 Active
US9777063B2 Neutralizing prolactin receptor antibody Mat3 and its therapeutic use Chemistry; Metallurgy 2 Active
US11660351B2 Antibody drug conjugates (ADCs) having enzymatically cleavable groups Chemistry; Metallurgy 2 Active
US9241989B2 Neutralizing prolactin receptor antibodies and their therapeutic use Chemistry; Metallurgy 1 Active
US9353186B2 Neutralizing prolactin receptor antibody Mat3 and its therapeutic use Chemistry; Metallurgy 1 Active
US11643469B2 Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodies Chemistry; Metallurgy 0 Active
US12059472B2 Prodrugs of cytotoxic active agents having enzymatically cleavable groups Chemistry; Metallurgy 0 Active
US11806404B2 Site specific homogeneous with KSP inhibitors Chemistry; Metallurgy 0 Active
US12331094B2 Atrial natriuretic peptide engrafted antibodies Chemistry; Metallurgy 0 Active
US12144865B2 Antibody drug conjugates with enzymatically cleavable groups Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.